Figure 3: A pre-vascular lymph node in Subject-1. The baseline RGD-K5 SUVmax measured before treatment is 5.5, and the value is decreased to 3.7 after receiving 4 doses of bevacizumab. The FDG uptake is comparable. The size measured on CT is 1.8×1.1 cm on the baseline scan, and 1.1×0.7 on the follow-up scan. The pre-treatment FDG SUVmax is 4.0, and is decreased to 2.8 after 4 doses of bevacizumab.